Johnson & Johnson (JNJ) is expected to report earnings on Tuesday, October 13, 2026, after the close. Estimated release time 07:41 ET. Consensus EPS estimate is $2.95.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-15 | FY2026 Q2 | $2.84 | $2.90 | +2.1% | $25.31B |
| 2026-04-22 | FY2026 Q1 | $2.68 | $2.70 | +0.7% | $24.06B |
| 2026-02-11 | FY2025 Q4 | $2.46 | $2.46 | +0.0% | $24.56B |
| 2025-10-22 | FY2025 Q3 | $2.76 | $2.80 | +1.4% | $23.99B |
| 2025-07-24 | FY2025 Q2 | $2.68 | $2.77 | +3.4% | $23.74B |
| 2025-04-23 | FY2025 Q1 | $2.58 | $2.77 | +7.4% | $21.89B |
| 2025-02-13 | FY2024 Q4 | $1.99 | $2.04 | +2.5% | $22.52B |
| 2024-10-23 | FY2024 Q3 | $2.21 | $2.42 | +9.5% | $22.47B |
JNJ has beaten consensus EPS in 8 of its last 8 reported quarters.
See JNJ on the live calendar →